mRNA Expression levels of genes involved in antitumor immunity: Identification of a 3-gene signature associated with prognosis of muscle-invasive bladder cancer

Rationale for anti-OX40 cancer immunotherapy

(2016) Sandrine Aspeslagh et al.   EUROPEAN JOURNAL OF CANCER

Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal

(2016) Wojciech Jóźwicki et al.   Oncotarget

A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition

(2015) M. P. Mak et al.   CLINICAL CANCER RESEARCH

Immune Checkpoint Inhibitors for Urologic Cancer: The Tip of the Iceberg?

(2015) Tom Powles   EUROPEAN UROLOGY

The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer

(2015) T. Horn et al.   WORLD JOURNAL OF UROLOGY

The checkpoint inhibitor TIGIT limits antitumor and antiviral CD8+T cell responses

(2015) Robert J Johnston et al.   OncoImmunology

CD8+ and FOXP3+ Tumor-Infiltrating T Cells Before and After Chemoradiotherapy for Rectal Cancer

(2014) Eiji Shinto et al.   ANNALS OF SURGICAL ONCOLOGY

The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function

(2014) Robert J. Johnston et al.   CANCER CELL

Shaping of an effective immune microenvironment to and by cancer cells

(2014) Etienne Becht et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The perspective of immunotherapy

(2014) Christian U. Blank   CURRENT OPINION IN ONCOLOGY

Adult-Onset Immunodeficiency in Thailand and Taiwan

(2012) Sarah K. Browne et al.   NEW ENGLAND JOURNAL OF MEDICINE

Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction

(2011) Junzhou Niu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer

(2010) Zhengbin Shen et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer

(2009) Hiroyuki Suzuki et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Large-scale Real-time Reverse Transcription-PCR Approach of Angiogenic Pathways in Human Transitional Cell Carcinoma of the Bladder: Identification of VEGFA as a Major Independent Prognostic Marker

(2008) Géraldine Pignot et al.   EUROPEAN UROLOGY